Hurix's Ferovid Herbs Capsule
Hurix's Ferovid Herbs Capsule : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.
NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.
Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0
- Registration number
- MAL24036133TC
- Type
- Natural product
- Published status
- PRODUCT APPROVED
- Licence holder
- JIN BIN CORPORATION SDN. BHD.
- Manufacturer
- J.B. PHARMACY GROUP SDN. BHD.
- Registration period starting
- 2024-03-07
- Published validity end
- 2029-03-07
The foreign register category does not determine the regulatory category of the product in France.
French and European references for recognised ingredients
- Conditions légales
Glycyrrhiza uralensis Fisch.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.
Published composition
| Published ingredient | Published text and quantity | Identified nutrient or substance |
|---|---|---|
| Forsythia suspensa | Forsythia suspensa[75.200 mg,470 mg] | Not identified |
| Prunus armeniaca | Prunus armeniaca[84.600 mg,470 mg] | Not identified |
| Scutellaria baicalensis | Scutellaria baicalensis[18.800 mg,470 mg] | Not identified |
| Ligusticum chuanxiong | Ligusticum chuanxiong[75.200 mg,470 mg] | Not identified |
| Tussilago farfara | Tussilago farfara[56.400 mg,470 mg] | Not identified |
| Pogostemon cablin | Pogostemon cablin[75.200 mg,470 mg] | Not identified |
| Glycyrrhiza uralensis | Glycyrrhiza uralensis[37.600 mg,470 mg] | Not identified |
| Lonicera japonica | Lonicera japonica[94.000 mg,470 mg] | Not identified |
| Pinellia ternata | Pinellia ternata[65.800 mg,470 mg] | Not identified |
| Mentha haplocalyx | Mentha haplocalyx[56.400 mg,470 mg] | Not identified |
| Platycodon grandiflorum | Platycodon grandiflorum[56.400 mg,470 mg] | Not identified |
| Peucedanum praeruptorum | Peucedanum praeruptorum[75.200 mg,470 mg] | Not identified |
| Cinnamomum cassia | Cinnamomum cassia[56.400 mg,470 mg] | Not identified |
| Isatis indigotica | Isatis indigotica[75.200 mg,470 mg] | Not identified |
| Scutellaria baicalensis | Scutellaria baicalensis[37.600 mg,470 mg] | Not identified |
The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.
Original register data
View published fields and their variants
- Active ingredients
- Forsythia suspensa[75.200 mg,470 mg],Prunus armeniaca[84.600 mg,470 mg],Scutellaria baicalensis[18.800 mg,470 mg],Ligusticum chuanxiong[75.200 mg,470 mg],Tussilago farfara[56.400 mg,470 mg],Pogostemon cablin[75.200 mg,470 mg],Glycyrrhiza uralensis[37.600 mg,470 mg],Lonicera japonica[94.000 mg,470 mg],Pinellia ternata[65.800 mg,470 mg],Mentha haplocalyx[56.400 mg,470 mg],Platycodon grandiflorum[56.400 mg,470 mg],Peucedanum praeruptorum[75.200 mg,470 mg],Cinnamomum cassia[56.400 mg,470 mg],Isatis indigotica[75.200 mg,470 mg],Scutellaria baicalensis[37.600 mg,470 mg]
- Valid until
- 2029-03-07
- Registration date
- 2024-03-07
- Published description
- NATURAL PRODUCT
- Licence holder
- JIN BIN CORPORATION SDN. BHD.
- Producer
- J.B. PHARMACY GROUP SDN. BHD.
- Published name
- Hurix's Ferovid Herbs Capsule
- Published reference
- 2023071711958T
- Registration number
- MAL24036133TC
- Published status
- PRODUCT APPROVED
Official source
View the official register, number MAL24036133TC
Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Glycyrrhiza uralensis
Read the warning, when it applies and the studies cited
DEGLYCYRRHIZINATED LICORICE Buccal
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Health Canada monograph dated 31 October 2025
Deglycyrrhizinated Licorice Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Health Canada monograph dated 31 January 2025
LICORICE
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (Gardner and McGuffin 2013).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: Cough relief.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if cough worsens or persists (for) more than 1 week (EMA 2012).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: Gastritis relief.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Contraindications
Condition of application: All products.
Do not use if you are pregnant (EMA 2012).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Do not use if you have hypokalemia, high blood pressure, or a kidney, liver or cardiovascular disorder (EMA 2012; Brinker 2010; ESCOP 2003; Bradley 1992).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Do not use if you are taking heart medications, corticosteroids, stimulant laxatives, or other health products that may contribute electrolyte imbalance (Brinker 2010; ESCOP 2003; Hoffmann 2003; Blumenthal et al. 2000).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
- Cinnamomum cassia
Read the warning, when it applies and the studies cited
CASSIA - CINNAMOMUM AROMATICUM
Route of administration: Oral
Cautions and warnings
Condition of application: Appetite loss; Digestive disturbances/Indigestion; Traditional Chinese Medicine claims.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Products providing 1 g or more of branch bark, stem bark and/or trunk bark, per day
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (Blumenthal et al. 2000; WHO 1999).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Gardner and McGuffin 2013; Brinker 2010).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Contraindications
Applies to products providing 1 g or more of branch bark, stem bark and/or trunk bark, per day.
Do not use if you are pregnant (PPRC 2020; Brinker 2010; BHC 2006; Chen and Chen 2004; Blumenthal 2000, 1998).
6 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: Traditional Chinese Medicine claims.
Do not use if you have excess heat, blood heat or deficiency, or yin-deficient fire (PPRC 2020; Bensky et al. 2004; Chen and Chen 2004).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (Gardner and McGuffin 2013; Blumenthal 2000; WHO 1999).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.